All research products on this site, including all peptides, are sold strictly for laboratory and research use only, not for human or animal consumption, diagnostic, or therapeutic use. Our tallow skincare products are topical cosmetics. You must be 21 or older to enter.
By entering you confirm you are 21+ and accept these products are for research use only. See our Terms and Disclaimer.
BPC-157 is the pentadecapeptide studied in tissue-repair research, supplied as a research oral thin film.
New product line: orders ship from Nov 9, then 2-Day Priority Air.
Complete the order
Supplies and compounds researchers add to this order
Identity, purity and handling data for this compound, in one place. Tap an identifier to copy it.
A third-party certificate for BPC-157 Oral Thin Film is not published here yet. If your work needs one, ask us before ordering and we will tell you what testing is available for the current lot.
Ask about a certificateFor research use only. Not for human consumption.
BPC-157 is supplied in oral thin film (OTF) format: thin, dissolvable film strips packed in a box.
BPC-157 (Body Protection Compound-157) is a pentadecapeptide consisting of 15 amino acids, derived from a partial sequence of human gastric juice protein BPC. It was first described in the early 1990s, and since then has been extensively studied in preclinical models for its effects on tissue repair, angiogenesis, and gastrointestinal function.
A substantial body of peer-reviewed research, largely conducted in rodent models, has investigated BPC-157's interactions with the nitric oxide (NO) system, growth hormone receptors, and vascular endothelial growth factor (VEGF) pathways. These studies have examined its stability in gastric acid and its systemic availability following different routes of administration in controlled laboratory settings.
BPC-157 has attracted significant scientific attention due to its apparent multi-tissue activity in research models, with studies spanning tendon, muscle, bone, nerve, and gastrointestinal tissue. Its mechanism of action remains an active area of investigation, with researchers exploring interactions between this peptide and multiple signaling networks involved in cellular repair and cytoprotection.
The areas where this compound appears in the published research literature.
BPC-157 research in tendon and muscle models typically involves surgical transection or crush injury in rodents, followed by localized or systemic administration of the peptide. Outcome measures include biomechanical tensile strength testing of repaired tissue, histological scoring of collagen fiber organization, and immunohistochemical staining for fibroblast and endothelial cell markers.
Gastrointestinal studies employ chemically induced lesion models (cysteamine, indomethacin, alcohol) in rats, with BPC-157 administered before or after injury. Researchers measure lesion area via endoscopic or gross pathology examination, alongside molecular markers of inflammation such as TNF-alpha, IL-1 beta, and COX-2 expression in gastric tissue samples.
Keep the package sealed and store it as labeled on the product, away from heat, direct light and moisture.
Supplied for laboratory research use only. Not for human or animal use, and not intended to diagnose, treat, cure, or prevent any disease.
BPC-157 Oral Thin Film for sale from Optimum ReGen Peptides, a US research-peptide company with a storefront in Medford, Oregon. It is in stock, priced from $225. Every order ships 2-Day Priority Air, a $13 flat rate anywhere in the US, with tracking, or can be picked up at the store.
BPC-157 Oral Thin Film is supplied as oral thin film (otf), boxed, for laboratory and research use only, not for human consumption.
